PARTNERING

Partnering opportunities

Laverock’s unique platform facilitates product development opportunities across a wide range of applications

  

Cell

Conditionally hypoimmunogenic cells.  Facilitating allogeneic product development with improved safety profiles.

Computer

Programmed cell differentiation. Consistent product quality and quantity in stem cell-derived allogeneic therapeutics.

Tissue responses

Conditional tissues responses for programmable immunotherapies. Programmed immune effectors cells for oncology.

Viral resistance

Programmed viral resistance. Novel therapeutics resistant to patient viral status, and viral contamination during manufacturing.

Current partners

Innovate UK Logo
Share by: